# In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso

> **NCT00808951** · PHASE4 · COMPLETED · sponsor: **Centre Muraz** · enrollment: 440 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate-amodiaquine
- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT00808951
- **Lead sponsor:** Centre Muraz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-10
- **Final completion:** 2011-02
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2015-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00808951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00808951, "In Vivo and in Vitro Efficacy of Antimalarial Treatments in Children in Burkina Faso". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00808951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*